サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：呼吸器吸入装置の世界市場レポート 2024年
市場調査レポート
商品コード
1415761

呼吸器吸入装置の世界市場レポート 2024年

Respiratory Inhaler Devices Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
呼吸器吸入装置の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

呼吸器吸入装置市場規模は近年力強く成長しています。2023年の385億4,000万米ドルから2024年には413億5,000万米ドルに、CAGR7.3％で成長します。実績期間の成長は、喫煙の流行、アレルギー疾患、医薬品の革新、高齢化などに起因しています。

呼吸器吸入装置市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR7.3％で547億2,000万米ドルに成長します。予測期間における成長は、空気の質に関する懸念、デジタルヘルス統合、吸入器の安全性に関する規制の重視、個別化治療などに起因すると考えられます。予測期間の主な動向には、吸入器デバイスの小型化、持続可能性と環境に優しい吸入器、在宅ケア、技術の進歩などがあります。

呼吸器疾患の有病率は増加傾向にあり、この現象が呼吸器吸入装置市場の成長を牽引します。呼吸器疾患には、肺や呼吸器系に影響を及ぼすさまざまな疾患が含まれ、しばしば呼吸困難や肺機能の低下をもたらします。これらの疾患には、喘息、慢性閉塞性肺疾患（COPD）、呼吸器合胞体ウイルス感染症、その他さまざまな呼吸器疾患が含まれます。呼吸器吸入装置の活用は、薬剤を肺に直接送り込み、呼吸器疾患と闘っている人々に迅速かつ的確な救済を提供するために不可欠です。一例として、米国を拠点とする著名な公衆衛生機関である疾病対策予防センター（Centers for Disease Control and Prevention）の最近のデータから、米国で報告された結核症例が増加し、2021年の7,874例から2022年には8,300例に達することが明らかになった。このデータは、呼吸器吸入装置市場の拡大を後押しする呼吸器疾患の有病率の増加による大きな推進力を強調しています。

喫煙率の急増は、呼吸器吸入装置市場の成長における主要な促進要因になると予測されています。喫煙は、植物の燃焼から発生する蒸気を吸ったり吐いたりすることであり、タバコが最も一般的な原因です。喫煙は、気道や肺胞と呼ばれる小さな肺の気嚢に大きなダメージを与え、喘息、COPD、気管支炎などの肺疾患の発症につながる可能性があります。このような状況において、呼吸器吸入装置は、喫煙に関連する問題によって引き起こされる呼吸器系の苦痛を緩和し、予防するために不可欠なツールとしての役割を果たします。驚くべきことに、米国疾病予防管理センター（Centers for Disease Control and Prevention）の報告によると、2021年には、米国の成人の約11.5％（推定2830万人）が喫煙者でした。その結果、1600万人以上のアメリカ人が喫煙に起因する病気と闘っています。したがって、喫煙率の上昇は呼吸器吸入装置市場を推進する強力な力となっています。

2023年の呼吸器吸入装置市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域と予想されます。呼吸器吸入装置レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東およびアフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の呼吸器吸入装置市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ドライパウダー吸入器
  • 定量吸入器
  • ネブライザー
  • 世界の呼吸器吸入装置市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 手動吸入器
  • デジタル操作の吸入装置
  • 世界の呼吸器吸入装置市場、疾患適応別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 喘息
  • 慢性閉塞性肺疾患
  • 肺動脈高血圧
  • その他の適応症
  • 世界の呼吸器吸入装置市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院と診療所
  • 呼吸器ケアセンター
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の呼吸器吸入器市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の呼吸器吸入器市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 呼吸器吸入装置市場の競合情勢
  • 呼吸器吸入装置市場の企業プロファイル
    • Merck &Co. Inc.
    • Novartis AG
    • AstraZeneca plc
    • Gerresheimer AG
    • GlaxoSmithKline plc

第31章 その他の主要および革新的な企業

  • 3M
  • Boehringer Ingelheim International GmbH
  • Koninklijke Philips N.V.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • Perrigo Company plc
  • AptarGroup Inc.
  • Recipharm AB
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Zydus Lifesciences Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12360

“Respiratory Inhaler Devices Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory inhaler devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The respiratory inhaler devices market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Technology: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease; Pulmonary Arterial Hypertension; Other Indications
  • 4) By End User: Hospitals And Clinics; Respiratory Care Centers; Other End Users
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; AstraZeneca plc; Gerresheimer AG; GlaxoSmithKline plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Respiratory inhaler devices are compact, handheld tools designed to administer medication directly to the lungs. They are specifically engineered to deliver medications to the respiratory system, with a focus on the lungs, which helps minimize systemic drug effects and provides rapid relief during respiratory attacks or exacerbations.

The primary categories of respiratory inhaler device products include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers (DPIs) are medical devices that dispense powdered medications directly to the lungs for the treatment of respiratory conditions. These inhaler devices encompass both manually operated and digitally operated options. They are commonly used in the management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other respiratory issues. Respiratory inhaler devices find application in various healthcare settings, including hospitals, clinics, respiratory care centers, and other medical facilities. They serve as important tools for the delivery of respiratory medications and the management of respiratory conditions.

The respiratory inhaler devices market research report is one of a series of new reports from The Business Research Company that provides respiratory inhaler devices market statistics, including respiratory inhaler devices industry global market size, regional shares, competitors with a respiratory inhaler devices market share, detailed respiratory inhaler devices market segments, market trends and opportunities and any further data you may need to thrive in the respiratory inhaler devices industry. This respiratory inhaler devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $38.54 billion in 2023 to $41.35 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population.

The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $54.72 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to air quality concerns, digital health integration, regulatory emphasis on inhaler safety, personalized treatment. Major trends in the forecast period include inhaler device miniaturization, sustainability and eco-friendly inhalers, home-based care, technological advancements.

The prevalence of respiratory diseases is on the rise, and this phenomenon is poised to steer the growth of the respiratory inhaler devices market. Respiratory diseases encompass a spectrum of disorders that affect the lungs and the respiratory system, often resulting in breathing difficulties and compromised lung function. These conditions include ailments like asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection, and various other respiratory disorders. The utilization of respiratory inhaler devices is essential in delivering medications directly to the lungs, providing swift and precise relief for individuals battling respiratory illnesses. As an example, recent data from the Centers for Disease Control and Prevention, a prominent US-based public health organization, revealed an increase in tuberculosis (TB) cases reported in the United States, reaching 8,300 cases in 2022, up from 7,874 cases in 2021. This data underscores the significant impetus resulting from the growing prevalence of respiratory diseases, which propels the expansion of the respiratory inhaler devices market.

The burgeoning rates of smoking are anticipated to be a key driver in the growth of the respiratory inhaler devices market. Smoking entails the inhalation and exhalation of vapors generated from the combustion of plant substances, with tobacco being the most common source. Smoking has the potential to inflict substantial damage to the airways and the tiny lung air sacs, known as alveoli, potentially leading to the development of lung diseases such as asthma, COPD, and bronchitis. In this context, respiratory inhaler devices serve as indispensable tools in mitigating and preventing respiratory distress caused by smoking-related issues. Remarkably, the Centers for Disease Control and Prevention reported that nearly 11.5% of adults in the United States, representing an estimated 28.3 million individuals, were smokers in 2021. Consequently, more than 16 million Americans grapple with ailments stemming from smoking. Hence, the upsurge in smoking rates is a potent force propelling the respiratory inhaler devices market.

The primary obstacle facing the respiratory inhaler devices market during the projected period is the lack of patient adherence to prescribed medications. Non-adherence to prescribed treatments can lead to suboptimal inhalation therapy outcomes and a subsequent increase in healthcare costs. This issue encompasses patients who may not adhere to their prescribed medication regimens, a behavior that is notably prevalent among individuals managing chronic conditions with substantial health implications. Illustratively, data from April 2022, sourced from the American Journal of Managed Care, revealed that approximately 50% of individuals failed to follow the prescribed treatment plan for their chronic, long-term medications. Poor adherence contributes to over $500 billion in avoidable healthcare expenditures annually, potentially preventable fatalities numbering over 125,000, and up to 25% of hospitalizations in the United States. Consequently, the lack of patient adherence to prescribed medications serves as a significant constraint in the growth of the respiratory inhaler devices market.

Prominent companies within the respiratory inhaler devices market are increasingly adopting advanced technologies, such as metered dosage inhalers (MDIs), to fortify their market standing. MDIs represent portable aerosol devices designed to deliver precise medication doses to the lungs in the form of an inhaled mist or spray. For instance, a noteworthy development occurred in February 2022, when AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital respiratory health solution effectively transforms conventional metered dosage inhalers (pMDIs) into intelligent and connected medical devices. HeroTracker Sense aims to monitor the utilization of MDIs by patients, promoting better adherence to prescribed therapies and ultimately enhancing the lives of individuals worldwide grappling with chronic respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory complications triggered by COVID-19. HeroTracker Sense further offers invaluable analytics and insights related to patient training, onboarding, and performance, serving healthcare providers (HCPs) through the Aptar Pharma Cohero Health BreatheSmart Connect portal.

In August 2022, AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, secured the global rights to the Orbital inhaler through an acquisition from Pharmaxis Ltd. This strategic acquisition of the Orbital inhaler rights aligns with Aptar Pharma's mission to expand its respiratory device portfolio and provide innovative solutions catering to patients grappling with respiratory conditions. Pharmaxis Ltd., an Australian-based pharmaceutical company with a clinical-stage focus, developed the groundbreaking Orbital dry powder inhaler. This strategic acquisition demonstrates a commitment to advancing respiratory care.

Major players in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc .

North America was the largest region in the respiratory inhaler devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory inhaler devices market consists of revenues earned by entities by providing services such as the management of chronic lung diseases and minimizing systemic effects of the drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory inhaler devices market also includes sales of compressed air nebulizers, ultrasonic nebulizers and mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Respiratory Inhaler Devices Market Characteristics

3. Respiratory Inhaler Devices Market Trends And Strategies

4. Respiratory Inhaler Devices Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Respiratory Inhaler Devices Market Size and Growth

  • 5.1. Global Respiratory Inhaler Devices Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Respiratory Inhaler Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Respiratory Inhaler Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Respiratory Inhaler Devices Market Segmentation

  • 6.1. Global Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Other Indications
  • 6.4. Global Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Respiratory Care Centers
  • Other End Users

7. Respiratory Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Respiratory Inhaler Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Respiratory Inhaler Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Respiratory Inhaler Devices Market

  • 8.1. Asia-Pacific Respiratory Inhaler Devices Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Respiratory Inhaler Devices Market

  • 9.1. China Respiratory Inhaler Devices Market Overview
  • 9.2. China Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Respiratory Inhaler Devices Market

  • 10.1. India Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Respiratory Inhaler Devices Market

  • 11.1. Japan Respiratory Inhaler Devices Market Overview
  • 11.2. Japan Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Respiratory Inhaler Devices Market

  • 12.1. Australia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Respiratory Inhaler Devices Market

  • 13.1. Indonesia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Respiratory Inhaler Devices Market

  • 14.1. South Korea Respiratory Inhaler Devices Market Overview
  • 14.2. South Korea Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Respiratory Inhaler Devices Market

  • 15.1. Western Europe Respiratory Inhaler Devices Market Overview
  • 15.2. Western Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Respiratory Inhaler Devices Market

  • 16.1. UK Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Respiratory Inhaler Devices Market

  • 17.1. Germany Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Respiratory Inhaler Devices Market

  • 18.1. France Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Respiratory Inhaler Devices Market

  • 19.1. Italy Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Respiratory Inhaler Devices Market

  • 20.1. Spain Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Respiratory Inhaler Devices Market

  • 21.1. Eastern Europe Respiratory Inhaler Devices Market Overview
  • 21.2. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Respiratory Inhaler Devices Market

  • 22.1. Russia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Respiratory Inhaler Devices Market

  • 23.1. North America Respiratory Inhaler Devices Market Overview
  • 23.2. North America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Respiratory Inhaler Devices Market

  • 24.1. USA Respiratory Inhaler Devices Market Overview
  • 24.2. USA Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Respiratory Inhaler Devices Market

  • 25.1. Canada Respiratory Inhaler Devices Market Overview
  • 25.2. Canada Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Respiratory Inhaler Devices Market

  • 26.1. South America Respiratory Inhaler Devices Market Overview
  • 26.2. South America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Respiratory Inhaler Devices Market

  • 27.1. Brazil Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Respiratory Inhaler Devices Market

  • 28.1. Middle East Respiratory Inhaler Devices Market Overview
  • 28.2. Middle East Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Respiratory Inhaler Devices Market

  • 29.1. Africa Respiratory Inhaler Devices Market Overview
  • 29.2. Africa Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Respiratory Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Inhaler Devices Market Competitive Landscape
  • 30.2. Respiratory Inhaler Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. AstraZeneca plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Gerresheimer AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Respiratory Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. 3M
  • 31.2. Boehringer Ingelheim International GmbH
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Viatris Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Catalent Inc.
  • 31.7. Perrigo Company plc
  • 31.8. AptarGroup Inc.
  • 31.9. Recipharm AB
  • 31.10. Chiesi Farmaceutici S.p.A.
  • 31.11. Cipla Limited
  • 31.12. Hikma Pharmaceuticals plc
  • 31.13. Zydus Lifesciences Limited
  • 31.14. Lupin Limited
  • 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Respiratory Inhaler Devices Market Competitive Benchmarking

33. Global Respiratory Inhaler Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Respiratory Inhaler Devices Market

35. Respiratory Inhaler Devices Market Future Outlook and Potential Analysis

  • 35.1 Respiratory Inhaler Devices Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Inhaler Devices Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Inhaler Devices Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer